Agency Information Collection Activities; Announcement of OMB Approval; Shipment of a Blood Product Prior to Completion of Testing for Hepatitis B Surface Antigen (HbsAg); and Shipment of Blood Products Known Reactive for HBsAg

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Shipment of a Blood Product Prior to Completion of Testing for Hepatitis B Surface Antigen (HbsAg); and Shipment of Blood Products Known Reactive for HBsAg" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.